Glioblastoma breakthrough: 40-year-old dad is brain cancer-free after groundbreaking immunotherapy trial

Ben Trotman, diagnosed with terminal glioblastoma in 2022, experienced a complete remission after receiving ipilimumab before standard treatment as part of an NHS-funded trial. His remarkable recovery, with scans showing no recurrence, has paved the way for a new clinical trial led by Dr. Paul Mulholland, offering hope to others battling this aggressive brain cancer.

Most Recent